Cite
APA Citation
Watanabe, K., Kage, H., Nagoshi, S., Toyama, K., Ohno, Y., Shinozaki-Ushiku, A., Nakazaki, K., Suzuki, H., Kurokawa, M., & Nagase, T. (2020). dual EGFR and ABL Tyrosine Kinase Inhibitor Treatment in a Patient with Concomitant EGFR-Mutated Lung Adenocarcinoma and BCR-ABL1-Positive CML. Case reports in oncological medicine, 2020, . http://access.bl.uk/ark:/81055/vdc_100109911654.0x000020